Restoration of hepatic lncSHGL has been found to improve hyperglycemia, insulin resistance (IR), and steatosis in obese diabetic mice, suggesting that activating the lncSHGL/hnRNPA1 axis could be a potential strategy for the treatment of T2DM and steatosis [78]. This evidence concerns the gene HNRNPA1 and steatosis.